Vectura Group announces global agreement with Hikma to develop generic versions of GSK’s Ellipta® portfolio
November 08, 2018 07:00 ET
|
Vectura Group plc
Vectura Group announces global agreement with Hikma to develop generic versions of GSK’s Ellipta® portfolio Upfront payment of US$15mUp to US$80m of development milestone payments Mid teen...